| Mr John Partridge
| Mr John M. Partridge is an independent director of Cigna Corp since January 26, 2009. Mr Partridge was appointed as President of Visa Inc in October 2009. From October 2007 until October 2009, Mr. Partridge was the Chief Operating Officer of Visa Inc. He joined Visa U.S.A. in October 1999 and served as President and Chief Executive Officer of Inovant, the company that owns and operates VisaNet, from November 2000 until October 2007. From 1998 until joining Visa, Mr. Partridge served as Senior Vice President and Chief Information Officer of Unum Provident Corp., a disability insurance company, where he led a corporate restructuring initiative and had direct responsibility for technology and operations. From 1989 to 1998, Mr. Partridge was Executive Vice President for Credicorp Inc., where he was responsible for consumer banking, technology and operations. Prior to joining Credicorp Inc., Mr. Partridge held various management positions with Wells Fargo Bank. He currently serves as a member of the board of directors of Cigna Corp since. Mr. Partridge holds a Bachelor of Science degree in Economics from the University of California, Berkeley. |
| Ms Jane Henney
| On March 8, 2012, Cubist Pharmaceuticals, Inc. appointed Dr Jane Henney to its Board of Directors, or the Board. She is a Professor of Medicine at the University of Cincinnati College of Medicine and has served in that position since January 2008. From July 2003 to January 2008, she served as Senior Vice President and Provost of University of Cincinnati’s Academic Health Center. She has been an independent director at Cigna Corp since April 2004. Dr Henney was Senior Scholar at the Association of Academic Health Centers from 2001 to 2003 and Commissioner of the United States Food and Drug Administration (FDA) from 1998 to 2001. Prior to that, Dr Henney held the position of Vice President for Health Sciences at the University of New Mexico from 1994 to 1998 and Deputy Commissioner of Operations at the FDA from 1992 to 1994. Dr Henney is a medical oncologist and has held several positions at the National Cancer Institute, including Deputy Director from 1980 to 1985. Dr Henney also serves as a director of AmerisourceBergen Corporation and CIGNA Corporation. |
| Ms Donna Zarcone
| Ms Donna F. Zarcone is the President and Chief Executive Officer of The Economic Club of Chicago (a civic and business leadership organization) since February 2012. She is an independent director of Cigna Corp since February 11, 2005. She served as Interim President of The Economic Club of Chicago from October 2011 until February 2012 and as President and Chief Executive Officer of D. F. Zarcone & Associates LLC (a strategic advisory firm) from 2007 until February 2012. Ms. Zarcone served as the President and Chief Operating Officer of Harley-Davidson Financial Services, Inc. (a provider of wholesale and retail financing, insurance and credit card programs), a wholly-owned subsidiary of Harley-Davidson, Inc., from 1998 until 2006. She has been a Director of CDW LLC since 2011 and will retire as a Director of The Jones Group, Inc. in May 2012, a role she has held since 2007. She also served as Chairman of the Board of Eaglemark Savings Bank from 2002 to 2006. |
| Mr Isaiah Harris
| Mr Isaiah Harris is an Non-Executive Chairman at Cigna Corp since December 2009 and served as Vice-Chairman of the Board from July 2009 through December 2009. Mr Harris served as President and Chief Executive Officer of AT&T Advertising & Publishing — East (formerly BellSouth Advertising & Publishing Group, a communications services company) from 2005 until his retirement in 2007; and as President, BellSouth Enterprises, Inc. from 2004 until 2005. Mr Harris has served as an Independent Trustee of Wells Fargo Advantage Funds since 2008 and served as a Director of Deluxe Corporation from 2004 until 2011. Mr Harris was recognized by the Outstanding Directors Exchange as a 2010 Outstanding Director. |
| Mr David Cordani
| Mr David M. Cordani is a Director of Cigna Corp since October 28, 2009. Mr Cordani has served as Cigna’s Chief Executive Officer since December 2009 and as President since June 2008. He served as Chief Operating Officer from June 2008 until December 2009; President, Cigna HealthCare from 2005 until 2008; and Senior Vice President, Customer Segments & Marketing, Cigna HealthCare from 2004 until 2005. He has been employed by Cigna since 1991. |
| Mr James Rogers
| Mr James E. Rogers is an independent director at Cigna Corp since February 26, 2007. He has served as Chairman since 2007, and President, Chief Executive Officer and a member of the Board of Directors since 2006, of Duke Energy Corporation, an electric power company that supplies and delivers electricity and natural gas service. Mr. Rogers was Chairman and Chief Executive Officer of Cinergy Corp., a provider of electric and gas service, from 1994 until its merger with Duke Energy in 2006. He was Chairman, President and Chief Executive Officer of PSI Energy, Inc., a provider of electric and gas service, from 1988 until 1994. Mr. Rogers served as a director of Fifth Third Bancorp from 1995 to 2009 and currently serves as a director of CIGNA Corporation. |
| Mr Roman Martinez
| Mr Roman Martinez IV is an independent director at Cigna Corp since July 1, 2005. Mr Martinez has been a private investor since 2003. He retired as Managing Director of Lehman Brothers, an investment banking firm, in 2003, following a 31-year career with the firm. He is also a director of Bacardi Limited. |
| Mr Eric C. Wiseman
| Mr Eric C. Wiseman is a director at Lowe’s Companies Inc since November 1, 2011. Mr Wiseman has served as Chairman of the Board of Directors of VF since August 2008, as President of VF since March 2006 and as Chief Executive Officer since January 2008. He is an independent director at Cigna Corp since April 25, 2007. He served as Chief Operating Officer from March 2006 until January 2008. He was elected a director of VF in October 2006. Mr Wiseman joined VF in 1995 and has held a progression of leadership roles within and across VF’s coalitions. Mr Wiseman also serves as a director of CIGNA Corporation. |
| Mr William Zollars
| Mr William D. Zollars an independent director since May 2005. He is the former Chairman, President and Chief Executive Officer of YRC Worldwide (now known as YRC Freight), which position he held from November 1999 to July 2011. YRC Worldwide provides transportation and global logistics services. Mr. Zollars served as President of Yellow Transportation, Inc. from September 1996 through November 1999. From 1994 to 1996, Mr. Zollars was Senior Vice President of Ryder Integrated Logistics, and prior to that, Mr. Zollars held various executive positions with Eastman Kodak. Mr. Zollars serves on the boards of CIGNA Corporation and Prologis, Inc. Mr. Zollars also serves on the boards of United Way of Greater Kansas City and The Carlson School of Management at the University of Minnesota. |
| Mr Gerald Storch
| Mr. Storch, age 58, has served as Chief Executive Officer of Hudson’s Bay Company, a leading owner and operator of department stores, since 2015. He served as Chairman and Chief Executive Officer of Storch Advisors from November 2013 to January 2015. He served as Chairman of Toys"R"Us, Inc. since February 2006 to November 2013, and served as Chief Executive Officer of Toys"R"Us from February 2006 until May 2013. Prior to joining Toys"R"Us, Inc., Mr. Storch served as Vice Chairman of Target Corporation. He joined Target in 1993 as Senior Vice President of Strategy and served in roles of increasing seniority over the next 12 years. Prior to joining Target, Mr. Storch was a partner at McKinsey & Company. Mr. Storch is the Non-Executive Chairman of the Board of Directors of Supervalu, Inc. He Serve as director at Bristol-Myers Squibb. |
| Mr Giovanni Caforio
| Dr. Giovanni Caforio M.D., is Chief Executive Officer, Director of Bristol-Myers Squibb Company effective May 5, 2015. He has served as Chief Operating Officer, Director of the company effective May 5, 2015. He brings a broad range of experience to his role as chief operating officer. He joined Bristol-Myers Squibb in 2000 as vice president and general manager, Italy, and assumed leadership roles for Greece, South East Europe, and in 2004, was appointed senior vice president, European Marketing and Brand Commercialization. |
| Mr Alan Lacy
| Mr. Lacy, age 61 , has been the Senior Advisor to Oak Hill Capital Partners, L.P., a private equity investment firm, since 2007. From 1994 to 2006, he was employed by Sears, Roebuck and Co., a large retail company, and following its acquisition, Sears Holdings Corporation, a large broadline retailer. Mr. Lacy held executive level positions of increasing responsibility in finance and operations, including his service as Chief Executive Officer and Chairman of the Board from 2000 to 2005. He also served as Vice Chairman of Sears Holdings Corporation from 2005 to 2006. He is Chairman of the Board of Trustees of the National Parks Conservation Association. Mr. Lacy is a Director of The Western Union Company, The Hillman Companies, Inc. and Dave & Buster’s, Inc. He is also a Trustee of Fidelity Funds, Director at Bristol Myers Squibb . |
| Mr Michael Grobstein
| Michael Grobstein has served as a director since October 2001 and was elected as an outside director in December 2001. Mr. Grobstein serves as a director of BMS, as chairman of its audit committee and a member of its compensation and management development committee. Mr. Grobstein served as a director of Guidant Corporation from 1999 to 2006, at which time Guidant was acquired by Boston Scientific Corporation. During that period, he was chairman of Guidant’s audit committee and a member of its corporate governance committee. Mr. Grobstein worked with Ernst & Young LLP from 1964 to 1998, and was admitted as a partner in 1975. At Ernst & Young, Mr. Grobstein served as a Vice Chairman-International Operations from 1993 to 1998, as Vice Chairman-Planning, Marketing and Industry Services from 1987 to 1993, and Vice Chairman-Accounting and Auditing Services from 1984 to 1987. In these positions, Mr. Grobstein, among other things, oversaw the global strategic planning of the firm, was responsible for developing and implementing the firm’s worldwide audit service delivery process and consulted with multinational corporations on a wide variety of financial reporting matters. Mr. Grobstein is a certified public accountant in the United States and holds a B.Sc. in accounting from the University of Illinois. |
| Mr Togo West
| Mr. West was U.S. Secretary of the Army from 1993 to 1998 and U.S. Secretary of Veterans Affairs from 1998 to 2000. He has practiced law as a partner in the New York law firm of Patterson Belknap Webb and Tyler and was counsel to the D.C. based law firm of Covington & Burling. Mr. West also served as General Counsel to the Departments of Defense and the Navy. Prior to his appointment with the Army, he was Senior Vice President for Government Affairs with Northrop Corporation. More recently, he was President and CEO of the Joint Center for Political and Economic Studies. Mr. West is Chairman of TLI Leadership Group and serves on the boards of Krispy Kreme Doughnuts, Inc. and Bristol-Myers Squibb. |
| Mr Lewis Campbell
| Mr. Campbell, age 69, served as Executive Chairman and Interim Chief Executive Officer of Navistar International Corporation, a leading manufacturer of commercial trucks, buses, RVs, defense vehicles and engines, from August 2012 to April 2013. Mr. Campbell served as Non-Executive Chairman of Textron Inc. from December 2009 to August 2010 and served as Chairman and Chief Executive Officer of Textron from February 1999 through November 2009. Mr. Campbell is a Director of Sensata Technologies Holding N.V., and is a member of The Business Council. He Serve as director at Bristol-Myers Squibb. |
| Ms Laurie Glimcher
| Dr. Glimcher, age 60, has been the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School since 1990. She is a Fellow of the American Academy of Arts and Sciences, a member of the National Academy of Sciences USA, and a member of the Institutes of Medicine of the National Academy of Sciences. She is also a member of, and a past President of, the American Association of Immunologists. She was elected to the American Society of Clinical Investigation, the American Association of Physicians and the American Association for the Advancement of Science. Dr. Glimcher is a Director of Waters Corporation, and at Bristol Myers Squibb. |
| Ms Vicki Sato
| Dr. Sato, age 67, has been a professor of management practice at the Harvard Business School since July 2005. She served as professor of the practice of molecular and cell biology at Harvard University from July 2005 to October 2015. In 2005, Dr. Sato retired as President of Vertex Pharmaceuticals Incorporated, a global biotechnology company, where she was responsible for research and development, business and corporate development, commercial operations, legal, and finance. Dr. Sato also served as Chief Scientific Officer, Senior Vice President of Research and Development, and Chair of the Scientific Advisory Board at Vertex before being named President in 2000. Dr. Sato is a Director of PerkinElmer Corporation and BorgWarner, Inc. She serve as Director at Bristol-Myers Squibb seince 2006. |
| Mr Douglas H. Brooks
| Mr Douglas H. Brooks is a Director of Southwest Airlines Co since 2010. He has served as Chairman of the Board of Brinker International Inc., a casual dining restaurant company, since November 2004. Mr Brooks has also served as Brinker International’s Chief Executive Officer since January 2004, and as its President since January 1999. Mr Brooks has also served in other capacities for Brinker including as its Chief Operating Officer and as President of Chili’s Grill & Bar. Mr Brooks serves on the Board of Directors of Limbs for Life and is a member of the Professional Advisory Board for St. Jude Children’s Research Hospital. |
| David Levin
| Mr David F Levi is an Independent Director at Las Vegas Sands Corp since January 2015. |
| Mr Michael Mahoney
| Michael F. Mahoney became our President effective October 17, 2011. Prior to joining Boston Scientific, he served as Worldwide Chairman, Medical Devices and Diagnostics for Johnson & Johnson from January 2011 to September 2011. Prior to assuming this position, Mr. Mahoney served as Worldwide Company Group Chairman of Johnson & Johnson's DePuy franchise, an orthopedics and neurosciences business, from April 2007 through January 2011. From January 2001 through March 2007, Mr. Mahoney served as President and Chief Executive Officer of Global Healthcare Exchange (GHX), a provider of supply chain solutions and services that bring together hospitals, IDNs, manufacturers, distributors and GPOs. Mr. Mahoney began his career at General Electric Medical Systems, where he spent 12 years, culminating in the role of General Manager of the Healthcare Information Technology business. Mr. Mahoney earned a Finance degree from the University of Iowa and an M.B.A. from Wake Forest University. |
